Infinity Deep Brain Stimulation (DBS) IPG
ABBOTT MEDICAL · Decision date Mar 13, 2026
What did the FDA decide?
FDA records P140009/S129 as a supplement to PMA P140009, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 13, 2026.
FDA approval order statement
approval to consolidate manufacturing activities from two manufacturing facilities into a single manufacturing facility and to utilize new equipment at the consolidated manufacturing facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Mar 13, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P140009/S129
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MHY
- Decision code
- OK30
- Decision date
- Mar 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.
- Applicant
- Abbott Medical
- Product code
- MHY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140009 · Original PMA
BRIO NEUROSTIMULATION SYSTEM
P140009/S118 · Related supplement
Liberta RC DBS IPG (Model 62400)
P140009/S123 · Related supplement
Infinity Deep Brain Stimulation (DBS) IPG
P140009/S121 · Related supplement
Liberta RC DBS IPG
P140009/S125 · Related supplement
DBS Neurostimulation System
P140009/S122 · Related supplement
Infinity DBS System
P140009/S124 · Related supplement
Deep Brain Stimulation (DBS) Neurostimulation System
P140009/S127 · Related supplement
Infinity Deep Brain Stimulation (DBS) System
P140009/S128 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
P140009/S126 · Related supplement
8CH Infinity DBS Lead Kit, 30cm, 0.5, B; 8CH Infinity DBS Lead Kit, 30cm, 1.5, B; 8CH Infinity DBS Lead Kit, 40cm, 0
P140009/S129 received
Application receipt date recorded by FDA.
P140009/S129 · FDA decision
30-Day Notice
P140009/S130 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
P140009/S131 · Related supplement
Infinity Deep Brain Stimulation (DBS) IPG; Liberta RC DBS IPG
P140009/S132 · Related supplement
Liberta RC Deep Brain Stimulation (DBS) IPG
P140009/S134 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
P140009/S138 · Related supplement
Deep Brain Stimulation (DBS) IPG
P140009/S133 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
P140009/S140 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S139 · Related supplement
Infinity DBS IPG
P140009/S143 · Related supplement
Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator
P140009/S141 · Related supplement
Deep Brain Stimulation (DBS) EPG
P140009/S142 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S144 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BRIO NEUROSTIMULATION SYSTEMP140009 | ABBOTT MEDICAL | PMA approval | Jun 12, 2015 | FDA |
Liberta RC DBS IPG (Model 62400)P140009/S118 | ABBOTT MEDICAL | PMA supplement | Jul 28, 2025 | FDA |
Infinity Deep Brain Stimulation (DBS) IPGP140009/S123 | ABBOTT MEDICAL | PMA supplement | Aug 29, 2025 | FDA |
Liberta RC DBS IPGP140009/S121 | ABBOTT MEDICAL | PMA supplement | Sep 7, 2025 | FDA |
DBS Neurostimulation SystemP140009/S125 | ABBOTT MEDICAL | PMA supplement | Sep 25, 2025 | FDA |
Infinity DBS SystemP140009/S122 | ABBOTT MEDICAL | PMA supplement | Sep 26, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Nov 7, 2025 | FDA | |
Infinity Deep Brain Stimulation (DBS) SystemP140009/S127 | ABBOTT MEDICAL | PMA supplement | Dec 23, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 10, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Feb 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Apr 25, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Apr 30, 2026 | FDA | |
Liberta RC Deep Brain Stimulation (DBS) IPGP140009/S132 | ABBOTT MEDICAL | PMA supplement | Jul 2, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jul 17, 2026 | FDA | |
Deep Brain Stimulation (DBS) IPGP140009/S138 | ABBOTT MEDICAL | PMA supplement | Jul 26, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Aug 7, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
Infinity DBS IPGP140009/S139 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Deep Brain Stimulation (DBS) EPGP140009/S141 | ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MHY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 8, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Prestion Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P140009/S129
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



